Loading...
Loading...
NMRD| Name | Value |
|---|---|
| Revenues | 0.0K |
| Cost of Revenue | 0.0K |
| Gross Profit | 0.0K |
| Operating Expense | 1,541.3K |
| Operating I/L | -1,541.3K |
| Other Income/Expense | 1,305.5K |
| Interest Income | 0.0K |
| Pretax | -2,161.5K |
| Income Tax Expense | 1,925.7K |
| Net Income/Loss | -2,161.5K |
Nemaura Medical Inc. is a medical technology company specializing in the development and commercialization of diagnostic medical devices. Its flagship product, sugarBEAT, is a non-invasive continuous glucose monitoring device designed for individuals with Type I and Type II diabetes, as well as for screening pre-diabetic patients. The company also offers proBEAT, a wellness guidance system that provides prompts and educates users on factors affecting blood sugar profiles. Additionally, Nemaura Medical Inc. conducts diabetes prevention and reversal programs, generating revenue through the sale of its medical devices and related wellness services.
